• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高撒哈拉以南非洲地区临床试验方案的适用性:一项混合方法研究。

Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study.

作者信息

Vischer Nerina, Pfeiffer Constanze, Kealy Jennifer, Burri Christian

机构信息

Department of Medicines Research, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4051 Basel, Switzerland.

University of Basel, Petersplatz 1, 4003 Basel, Switzerland.

出版信息

Glob Health Res Policy. 2017 Apr 7;2:11. doi: 10.1186/s41256-017-0031-1. eCollection 2017.

DOI:10.1186/s41256-017-0031-1
PMID:29202079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5683382/
Abstract

BACKGROUND

The trial protocol is the most important document for clinical trials and describes not only the design and methodology of a study, but also all practical aspects. The suitability of the protocol has a direct impact on the execution and results of the trial. However, suitability is rarely addressed in trial practice and research. The aim of our study was to investigate protocol suitability and to identify suitability-enhancing measures for trials in sub-Saharan Africa.

METHODS

We used an exploratory mixed methods design. First, we interviewed 36 trial staff at different organisational levels in Ghana, Burkina Faso and Senegal. Second, we conducted an online survey among trial staff in sub-Saharan Africa to investigate trial protocol suitability based on the main themes distilled from the interviews.

RESULTS

Protocol suitability surfaced as a prominent topic in interviews with trial staff, critiqued for its lack of clarity, implementability and adaptation to trial participants as well as to the workforce and infrastructure available. Both qualitative and quantitative investigations identified local site staff involvement in protocol development as the most helpful mean of increasing protocol suitability. Careful assessment of the local context, capacity and cultures, and ensuring that staff understand the protocol were also cited as helpful measures.

CONCLUSIONS

Our data suggests that protocol suitability can be increased by discussing and reviewing the protocol with trial staff in advance. Involving operationally experienced staff would be most useful. For multicentre trials, we suggest that at least one trial staff member from each of the sites with the highest expected recruitment rates be involved in developing the protocol. Carefully assessing the context prior to study start is indispensable to ensuring protocol suitability and should particularly focus on the workforce and infrastructure available, as well as the needs and availability of trial participants. To allow for protocol suitability enhancing measures, planners must allocate enough time for trial preparation and solicit feedback and information on context at an early stage. Such prospective planning would increase implementability, efficiency and quality of trials in the long run.

摘要

背景

试验方案是临床试验最重要的文件,它不仅描述了研究的设计和方法,还涵盖了所有实际方面。方案的适用性对试验的执行和结果有直接影响。然而,在试验实践和研究中,适用性很少得到关注。我们研究的目的是调查方案的适用性,并确定撒哈拉以南非洲地区试验中提高适用性的措施。

方法

我们采用了探索性混合方法设计。首先,我们采访了加纳、布基纳法索和塞内加尔不同组织层面的36名试验工作人员。其次,我们对撒哈拉以南非洲地区的试验工作人员进行了在线调查,以根据访谈中提炼出的主要主题调查试验方案的适用性。

结果

方案适用性在对试验工作人员的访谈中成为一个突出的话题,因其缺乏清晰度、可实施性以及对试验参与者、劳动力和现有基础设施的适应性而受到批评。定性和定量调查都确定,让当地现场工作人员参与方案制定是提高方案适用性最有效的方法。仔细评估当地情况、能力和文化,以及确保工作人员理解方案也被认为是有帮助的措施。

结论

我们的数据表明,通过提前与试验工作人员讨论和审查方案,可以提高方案的适用性。让有实际操作经验的工作人员参与将最为有用。对于多中心试验,我们建议从预计招募率最高的每个站点至少选派一名试验工作人员参与方案制定。在研究开始前仔细评估情况对于确保方案适用性是必不可少的,尤其应关注现有的劳动力和基础设施,以及试验参与者的需求和可得性。为了采取提高方案适用性的措施,规划者必须为试验准备分配足够的时间,并在早期征求关于情况的反馈和信息。从长远来看,这种前瞻性规划将提高试验的可实施性、效率和质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/d950734aeca0/41256_2017_31_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/2e48b6c1505d/41256_2017_31_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/2b3c2a4ba468/41256_2017_31_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/fc4423feefe0/41256_2017_31_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/d950734aeca0/41256_2017_31_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/2e48b6c1505d/41256_2017_31_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/2b3c2a4ba468/41256_2017_31_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/fc4423feefe0/41256_2017_31_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0dc/5683382/d950734aeca0/41256_2017_31_Fig4_HTML.jpg

相似文献

1
Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study.提高撒哈拉以南非洲地区临床试验方案的适用性:一项混合方法研究。
Glob Health Res Policy. 2017 Apr 7;2:11. doi: 10.1186/s41256-017-0031-1. eCollection 2017.
2
"You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.“如果……你就能节省时间”——关于撒哈拉以南非洲地区减缓临床试验的内部因素的定性研究
PLoS One. 2017 Mar 16;12(3):e0173796. doi: 10.1371/journal.pone.0173796. eCollection 2017.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
A modified video-feedback intervention for carers of foster children aged 6 years and under with reactive attachment disorder: a feasibility study and pilot RCT.改良视频反馈干预对 6 岁及以下寄养儿童反应性依恋障碍照顾者的效果:一项可行性研究和初步随机对照试验
Health Technol Assess. 2022 Aug;26(35):1-106. doi: 10.3310/SLIZ1119.
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
6
Defining clinical trial quality from the perspective of resource-limited settings: A qualitative study based on interviews with investigators, sponsors, and monitors conducting clinical trials in sub-Saharan Africa.从资源有限环境的角度定义临床试验质量:一项基于对在撒哈拉以南非洲开展临床试验的研究者、申办者和监查员进行访谈的定性研究。
PLoS Negl Trop Dis. 2022 Jan 27;16(1):e0010121. doi: 10.1371/journal.pntd.0010121. eCollection 2022 Jan.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
The Good Clinical Practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa.《药物临床试验质量管理规范》指南及其解读——撒哈拉以南非洲地区临床试验团队的看法
Trop Med Int Health. 2016 Aug;21(8):1040-1048. doi: 10.1111/tmi.12734. Epub 2016 Jun 28.
9
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
10
Health providers' perceptions of clinical trials: lessons from Ghana, Kenya and Burkina Faso.医疗服务提供者对临床试验的看法:来自加纳、肯尼亚和布基纳法索的经验教训。
PLoS One. 2015 May 1;10(5):e0124554. doi: 10.1371/journal.pone.0124554. eCollection 2015.

引用本文的文献

1
Improving Trial Informativeness: A Rapid Review of Global Research on How to Ensure Trials Are Useful.提高试验信息性:关于如何确保试验有用的全球研究的快速综述
J Eval Clin Pract. 2025 Jun;31(4):e70147. doi: 10.1111/jep.70147.
2
Operational Differences between Product Development Partnership, Pharmaceutical Industry, and Investigator Initiated Clinical Trials.产品开发合作、制药行业和研究者发起的临床试验之间的运营差异。
Trop Med Infect Dis. 2024 Feb 29;9(3):56. doi: 10.3390/tropicalmed9030056.
3
Practical Guidelines for Standardised Resolution of Important Protocol Deviations in Clinical Trials Conducted in Sub-Saharan Africa.

本文引用的文献

1
The Impact of Protocol Amendments on Clinical Trial Performance and Cost.方案修正案对临床试验绩效和成本的影响。
Ther Innov Regul Sci. 2016 Jul;50(4):436-441. doi: 10.1177/2168479016632271.
2
Patient enrollment and logistical problems top the list of difficulties in clinical research: a cross-sectional survey.患者招募和后勤问题是临床研究中困难的首要问题:一项横断面调查。
BMC Med Res Methodol. 2016 May 4;16:50. doi: 10.1186/s12874-016-0151-1.
3
Enhancing clinical evidence by proactively building quality into clinical trials.通过在临床试验中积极构建质量来增强临床证据。
撒哈拉以南非洲地区开展的临床试验中重要方案偏离的标准化解决实用指南。
Ther Innov Regul Sci. 2024 May;58(3):395-403. doi: 10.1007/s43441-023-00604-3. Epub 2024 Jan 29.
4
Opportunities and challenges for decentralised clinical trials in sub-Saharan Africa: a qualitative study.撒哈拉以南非洲分散临床试验的机遇与挑战:一项定性研究。
BMJ Open. 2023 Sep 22;13(9):e075903. doi: 10.1136/bmjopen-2023-075903.
5
Fexinidazole for Human African Trypanosomiasis, the Fruit of a Successful Public-Private Partnership.非昔硝唑用于治疗人类非洲锥虫病,公私合作的成果。
Diseases. 2022 Oct 17;10(4):90. doi: 10.3390/diseases10040090.
6
COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?尼日利亚的新冠病毒疫苗有效性研究:何去何从?
J Glob Health. 2022 Aug 3;12:03055. doi: 10.7189/jogh.12.03055.
7
ARETTA: Assessing Response to Neoadjuvant Taxotere and Subcutaneous Trastuzumab in Nigerian Women With HER2-Positive Breast Cancer: A Study Protocol.阿雷塔:评估尼日利亚HER2阳性乳腺癌女性对新辅助多西他赛和皮下注射曲妥珠单抗的反应:一项研究方案。
JCO Glob Oncol. 2020 Jul;6:983-990. doi: 10.1200/GO.20.00043.
Clin Trials. 2016 Aug;13(4):439-44. doi: 10.1177/1740774516643491. Epub 2016 Apr 20.
4
Patient Engagement Practices in Clinical Research among Patient Groups, Industry, and Academia in the United States: A Survey.美国患者群体、行业和学术界临床研究中的患者参与实践:一项调查
PLoS One. 2015 Oct 14;10(10):e0140232. doi: 10.1371/journal.pone.0140232. eCollection 2015.
5
Lessons in participant retention in the course of a randomized controlled clinical trial.随机对照临床试验过程中受试者保留的经验教训。
BMC Res Notes. 2014 Oct 9;7:706. doi: 10.1186/1756-0500-7-706.
6
Conducting qualitative research within Clinical Trials Units: avoiding potential pitfalls.在临床试验单位开展定性研究:避免潜在陷阱。
Contemp Clin Trials. 2014 Jul;38(2):338-43. doi: 10.1016/j.cct.2014.06.002. Epub 2014 Jun 14.
7
Improving protocol design feasibility to drive drug development economics and performance.提高方案设计的可行性,以推动药物研发的经济性和绩效。
Int J Environ Res Public Health. 2014 May 12;11(5):5069-80. doi: 10.3390/ijerph110505069.
8
Doctors and vampires in sub-Saharan Africa: ethical challenges in clinical trial research.撒哈拉以南非洲的医生和吸血鬼:临床试验研究中的伦理挑战。
Am J Trop Med Hyg. 2014 Aug;91(2):213-215. doi: 10.4269/ajtmh.13-0630. Epub 2014 May 12.
9
Regulatory challenges associated with conducting multicountry clinical trials in resource-limited settings.在资源有限的环境中开展多国临床试验所面临的监管挑战。
J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1(0 1):S29-31. doi: 10.1097/QAI.0000000000000037.
10
Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia.了解研究者:一项定性研究,旨在调查在埃塞俄比亚实施本地研究者发起的临床研究的障碍和促进因素。
BMJ Open. 2013 Nov 27;3(11):e003616. doi: 10.1136/bmjopen-2013-003616.